DOJ’s New Focus on Corporate Crime and the Implications for the Governing Board
- November 05, 2021
- Michael W. Peregrine , McDermott Will & Emery LLP
By now, most health care lawyers are aware that the Department of Justice (DOJ) has announced a substantial shift in its enforcement posture with respect to corporate fraud and individual accountability. But they may be particularly interested in the unique governance implications of this new posture, and what may be important to share with the board of directors.
ARTICLE TAGS
You must be logged in to access this content.